114 related articles for article (PubMed ID: 26383863)
1. Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure.
Cao Z; Li F; Xiang X; Liu K; Liu Y; Tang W; Lin L; Guo Q; Bao S; Xie Q; Wang H
Sci Rep; 2015 Sep; 5():14240. PubMed ID: 26383863
[TBL] [Abstract][Full Text] [Related]
2. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure.
Lu J; Lin L; Ye C; Tao Q; Cui M; Zheng S; Zhu D; Liu L; Xue Y
Ann Hepatol; 2019; 18(1):155-164. PubMed ID: 31113585
[TBL] [Abstract][Full Text] [Related]
3. The value of dynamic changes in FT3 level for predicting 90-day prognosis of HBV-ACLF patients.
Zhang J; Zhang L; Fu X; Chen Y; Duan Z; Tian G
Eur J Med Res; 2024 May; 29(1):288. PubMed ID: 38750605
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis.
Tu H; Liu R; Zhang A; Yang S; Liu C
BMC Gastroenterol; 2023 Oct; 23(1):342. PubMed ID: 37789279
[TBL] [Abstract][Full Text] [Related]
5. The 90-Day Survival Threshold: A Pivotal Determinant of Long-Term Prognosis in HBV-ACLF Patients - Insights from a Prospective Longitudinal Cohort Study.
Xiao L; Chen J; Zhao S; Zhoudi W; He K; Qian X; Zhang F; Liu Q; Li T; Zhu D; Wu X; Pu Z; Huang J; Xie Z; Xu X
Adv Sci (Weinh); 2024 Apr; 11(16):e2304381. PubMed ID: 38380526
[TBL] [Abstract][Full Text] [Related]
6. Development of novel prognostic models based on dynamic changes in risk factors for hepatitis B associated acute-on-chronic liver failure:a 10-year retrospective study.
Fan W; Liao W; Jiang S; Chen Y; Li C; Liang X
Heliyon; 2024 Apr; 10(7):e29276. PubMed ID: 38617970
[TBL] [Abstract][Full Text] [Related]
7. Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure.
Zhou X; Luo J; Liang X; Li P; Ren K; Shi D; Xin J; Jiang J; Chen J; He L; Yang H; Ma S; Li B; Li J
Infect Drug Resist; 2024; 17():1185-1198. PubMed ID: 38560706
[TBL] [Abstract][Full Text] [Related]
8. NK-cell-elicited gasdermin-D-dependent hepatocyte pyroptosis induces neutrophil extracellular traps that facilitate HBV-related acute-on-chronic liver failure.
Zhao Q; Chen DP; Chen HD; Wang YZ; Shi W; Lu YT; Ren YZ; Wu YK; Pang YH; Deng H; He X; Kuang DM; Guo ZY
Hepatology; 2024 Mar; ():. PubMed ID: 38537134
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lactate/albumin ratio in patients with acute-on-chronic liver failure.
Golcuk Y; Golcuk BK
Ann Hepatol; 2023; 28(6):101161. PubMed ID: 37797826
[No Abstract] [Full Text] [Related]
10. Keratin 18-M65: A biomarker for early-stage alcohol-associated liver disease.
McClain CJ; Kirpich I; Song M; Vatsalya V
Alcohol Clin Exp Res (Hoboken); 2023 Jul; 47(7):1257-1260. PubMed ID: 37526591
[No Abstract] [Full Text] [Related]
11. Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.
Clark DN; Hu J
Antiviral Res; 2015 Nov; 123():132-7. PubMed ID: 26408354
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.
Liang HW; Wang N; Wang Y; Wang F; Fu Z; Yan X; Zhu H; Diao W; Ding Y; Chen X; Zhang CY; Zen K
J Hepatol; 2016 Feb; 64(2):278-291. PubMed ID: 26409216
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Core Protein Phosphorylation Sites Affect Capsid Stability and Transient Exposure of the C-terminal Domain.
Selzer L; Kant R; Wang JC; Bothner B; Zlotnick A
J Biol Chem; 2015 Nov; 290(47):28584-28593. PubMed ID: 26405031
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Recent Advances in HBV and HCV Immunology.
Dustin LB; Trehanpati N
Front Immunol; 2015; 6():453. PubMed ID: 26388875
[No Abstract] [Full Text] [Related]
15. Cleaved c-FLIP mediates the antiviral effect of TNF-α against hepatitis B virus by dysregulating hepatocyte nuclear factors.
Park YK; Park ES; Kim DH; Ahn SH; Park SH; Lee AR; Park S; Kang HS; Lee JH; Kim JM; Lee SK; Lim KH; Isorce N; Tong S; Zoulim F; Kim KH
J Hepatol; 2016 Feb; 64(2):268-277. PubMed ID: 26409214
[TBL] [Abstract][Full Text] [Related]
16. Anti-HBV Drugs: Progress, Unmet Needs, and New Hope.
Kang L; Pan J; Wu J; Hu J; Sun Q; Tang J
Viruses; 2015 Sep; 7(9):4960-77. PubMed ID: 26389937
[TBL] [Abstract][Full Text] [Related]
17. Discrete virus infection model of hepatitis B virus.
Zhang P; Min L; Pian J
Biomed Mater Eng; 2015; 26 Suppl 1():S2187-95. PubMed ID: 26405998
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.
Wang CC; Lin CL; Hsieh TY; Tseng KC; Peng CY; Su TH; Yang SS; Hsu YC; Chen TM; Kao JH
Hepatol Int; 2016 Mar; 10(2):294-301. PubMed ID: 26399763
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
Virine B; Osiowy C; Gao S; Wang T; Castillo E; Martin SR; Lee SS; Simmonds K; van Marle G; Coffin CS
PLoS One; 2015; 10(10):e0140070. PubMed ID: 26474400
[TBL] [Abstract][Full Text] [Related]
20. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
Zhang TY; Yuan Q; Zhao JH; Zhang YL; Yuan LZ; Lan Y; Lo YC; Sun CP; Wu CR; Zhang JF; Zhang Y; Cao JL; Guo XR; Liu X; Mo XB; Luo WX; Cheng T; Chen YX; Tao MH; Shih JW; Zhao QJ; Zhang J; Chen PJ; Yuan YA; Xia NS
Gut; 2016 Apr; 65(4):658-71. PubMed ID: 26423112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
